Emerging trends in combinations of gefitinib and cytotoxic agents: new opportunities.
Tabernero
Josep
J
Macarulla
Teresa
T
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy*; D002986:Clinical Trials as Topic / Q000639:trends; D004358:Drug Therapy / Q000379:methods / Q000639:trends; D000077156:Gefitinib; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D010818:Practice Patterns, Physicians' / Q000639:trends; D047428:Protein Kinase Inhibitors / Q000008:administration & dosage; D011799:Quinazolines / Q000008:administration & dosage*
D047428:Protein Kinase Inhibitors; D011799:Quinazolines; D000077156:Gefitinib